HY-123931-10mg
|
MedChemexpress LLC
|
ZLDI-8 [CAS 667880-38-8]
|
|
Cancer-programmed cell death
|
|
HY-123931-100mg
|
MedChemexpress LLC
|
ZLDI-8 [CAS 667880-38-8]
|
|
Cancer-programmed cell death
|
|
HY-123931-5mg
|
MedChemexpress LLC
|
ZLDI-8 [CAS 667880-38-8]
|
|
Cancer-programmed cell death
|
|
HY-123931-50mg
|
MedChemexpress LLC
|
ZLDI-8 [CAS 667880-38-8]
|
|
Cancer-programmed cell death
|
|
HY-123931-1mL
|
MedChemexpress LLC
|
ZLDI-8 [CAS 667880-38-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
N389945-500mg
|
Toronto Research Chemicals
|
Neo Heliopan AP Sodium Salt [CAS 226952-42-7]
|
|
|
|
N389945-1g
|
Toronto Research Chemicals
|
Neo Heliopan AP Sodium Salt [CAS 226952-42-7]
|
|
|
|
N389945-100mg
|
Toronto Research Chemicals
|
Neo Heliopan AP Sodium Salt [CAS 226952-42-7]
|
|
|
|